
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8159119
[patent_doc_number] => 20120100558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'LUNG CANCER DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/062929
[patent_app_country] => US
[patent_app_date] => 2009-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16382
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100558.pdf
[firstpage_image] =>[orig_patent_app_number] => 13062929
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/062929 | LUNG CANCER DIAGNOSIS | Aug 26, 2009 | Abandoned |
Array
(
[id] => 6599623
[patent_doc_number] => 20100098626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/547736
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 38441
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12547736
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547736 | Protein | Aug 25, 2009 | Issued |
Array
(
[id] => 6599652
[patent_doc_number] => 20100098627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/547743
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 36639
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20100098627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12547743
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547743 | PROTEINS | Aug 25, 2009 | Abandoned |
Array
(
[id] => 6348372
[patent_doc_number] => 20100021441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'MHC MOLECULE-BINDING TUMOR-ASSOCIATED PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/544117
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13876
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021441.pdf
[firstpage_image] =>[orig_patent_app_number] => 12544117
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/544117 | MHC molecule-binding tumor-associated peptides | Aug 18, 2009 | Issued |
Array
(
[id] => 6585506
[patent_doc_number] => 20100047868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Tumour Suppressor Protein'
[patent_app_type] => utility
[patent_app_number] => 12/537050
[patent_app_country] => US
[patent_app_date] => 2009-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8734
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047868.pdf
[firstpage_image] =>[orig_patent_app_number] => 12537050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/537050 | Tumour Suppressor Protein | Aug 5, 2009 | Abandoned |
Array
(
[id] => 6257909
[patent_doc_number] => 20100029748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Metastasis Promoting Genes and Proteins'
[patent_app_type] => utility
[patent_app_number] => 12/535583
[patent_app_country] => US
[patent_app_date] => 2009-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15431
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029748.pdf
[firstpage_image] =>[orig_patent_app_number] => 12535583
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/535583 | Metastasis Promoting Genes and Proteins | Aug 3, 2009 | Abandoned |
Array
(
[id] => 7811160
[patent_doc_number] => 08133690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Method for inhibiting the formation of SET1 family core complexes'
[patent_app_type] => utility
[patent_app_number] => 12/509874
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 21
[patent_no_of_words] => 6756
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/133/08133690.pdf
[firstpage_image] =>[orig_patent_app_number] => 12509874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/509874 | Method for inhibiting the formation of SET1 family core complexes | Jul 26, 2009 | Issued |
Array
(
[id] => 6149251
[patent_doc_number] => 20110020846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Oral cancer biomarker and inspection method using the same'
[patent_app_type] => utility
[patent_app_number] => 12/460656
[patent_app_country] => US
[patent_app_date] => 2009-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10187
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020846.pdf
[firstpage_image] =>[orig_patent_app_number] => 12460656
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/460656 | Oral cancer biomarker and inspection method using the same | Jul 21, 2009 | Abandoned |
Array
(
[id] => 6526662
[patent_doc_number] => 20100015045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Cancerous Disease Modifying Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/504473
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13365
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015045.pdf
[firstpage_image] =>[orig_patent_app_number] => 12504473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/504473 | Cancerous Disease Modifying Antibodies | Jul 15, 2009 | Abandoned |
Array
(
[id] => 5367107
[patent_doc_number] => 20090304666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/502011
[patent_app_country] => US
[patent_app_date] => 2009-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22556
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304666.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502011
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502011 | CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF | Jul 12, 2009 | Abandoned |
Array
(
[id] => 5944081
[patent_doc_number] => 20110104701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'PROTEIN DISULFIDE ISOMERASE ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/999242
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26917
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104701.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999242
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999242 | Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer | Jul 8, 2009 | Issued |
Array
(
[id] => 8282478
[patent_doc_number] => 08216578
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-10
[patent_title] => 'Antibodies to oncostatin M receptor'
[patent_app_type] => utility
[patent_app_number] => 12/497439
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24372
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12497439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/497439 | Antibodies to oncostatin M receptor | Jul 1, 2009 | Issued |
Array
(
[id] => 5551842
[patent_doc_number] => 20090285828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'Anti-PECAM Therapy for Metastasis Suppression'
[patent_app_type] => utility
[patent_app_number] => 12/497011
[patent_app_country] => US
[patent_app_date] => 2009-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11273
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285828.pdf
[firstpage_image] =>[orig_patent_app_number] => 12497011
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/497011 | Anti-PECAM Therapy for Metastasis Suppression | Jul 1, 2009 | Abandoned |
Array
(
[id] => 6348785
[patent_doc_number] => 20100021482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'NOVEL DEATH ASSOCIATED PROTEINS, AND THAP1 AND PAR4 PATHWAYS IN APOPTOSIS CONTROL'
[patent_app_type] => utility
[patent_app_number] => 12/482790
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 88049
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12482790
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/482790 | NOVEL DEATH ASSOCIATED PROTEINS, AND THAP1 AND PAR4 PATHWAYS IN APOPTOSIS CONTROL | Jun 10, 2009 | Abandoned |
Array
(
[id] => 8220789
[patent_doc_number] => 20120134995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'METHOD FOR PREDICTING THE THERAPEUTIC RESPONSEIVENESS OF A PATIENT TO A MEDICAL TREATMENT WITH AN EGFR INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/320299
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10012
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320299
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320299 | METHOD FOR PREDICTING THE THERAPEUTIC RESPONSEIVENESS OF A PATIENT TO A MEDICAL TREATMENT WITH AN EGFR INHIBITOR | May 14, 2009 | Abandoned |
Array
(
[id] => 5367132
[patent_doc_number] => 20090304691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/467170
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 23597
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467170 | Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof | May 14, 2009 | Issued |
Array
(
[id] => 5558279
[patent_doc_number] => 20090269856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR EVALUATING BREAST CANCER PROGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/466149
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26646
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269856.pdf
[firstpage_image] =>[orig_patent_app_number] => 12466149
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/466149 | METHODS AND COMPOSITIONS FOR EVALUATING BREAST CANCER PROGNOSIS | May 13, 2009 | Abandoned |
Array
(
[id] => 7685988
[patent_doc_number] => 20100120153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'N-GLYCOSYLATION MUTANT OF MELANOMA DIFFERENTIATION ASSOCIATED GENE-7'
[patent_app_type] => utility
[patent_app_number] => 12/434387
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10144
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12434387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/434387 | N-GLYCOSYLATION MUTANT OF MELANOMA DIFFERENTIATION ASSOCIATED GENE-7 | Apr 30, 2009 | Abandoned |
Array
(
[id] => 5302892
[patent_doc_number] => 20090297544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/432700
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17885
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297544.pdf
[firstpage_image] =>[orig_patent_app_number] => 12432700
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/432700 | Tumor antigen protein SART-3 and tumor antigen peptides thereof | Apr 28, 2009 | Issued |
Array
(
[id] => 6220595
[patent_doc_number] => 20100055690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/422530
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22128
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055690.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422530 | PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER | Apr 12, 2009 | Abandoned |